Uveal melanoma
Conditions
Interventions
Observation group:None
Sponsors
The Second Affiliated Hospital of Harbin Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who were diagnosed with uveal melanoma by pathological examination for the first time; 2. All included patients had not received any form of antitumor treatment before sample collection, including but not limited to chemotherapy, radiotherapy, targeted therapy, and immunotherapy; 3. The selected patients all received standard treatment plans after diagnosis; 4. All patients participating in the study had complete clinical data and 5-year follow-up records.
Exclusion criteria
Exclusion criteria: 1. Patients with severe cachexia; 2. Patients with mental illness, severe immune system disease, or severe hematologic disease; 3. Patients with a history of other tumors who have received related treatment; 4. Patients who have lost follow-up information within 5 years after pathological diagnosis; 5. Patients aged <=18 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Analysis of the correlation between clinicopathological features and prognosis in UM patients; | — |
Countries
China
Contacts
Public ContactLijun Qu
The Second Affiliated Hospital of Harbin Medical University
Outcome results
None listed